About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT04585880

Remote Monitoring and Virtual Collaborative Care For Hypertension Control To Prevent Cognitive Decline

This purpose of this study is to examine an aggressive method of blood pressure control that involves home blood pressure monitoring and management of medications by a team of clinical pharmacists in ...

Lead sponsor: University of Kansas Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Kansas Medical Center

Collaborators

National Institute on Aging (NIA)

Age

65 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age 65 and older
•Active patient in participating primary care clinic
•Access to compatible "smartphone" or device (i.e., Android, Kindle or Apple with internet connectivity)
•Elevated blood pressure as defined by:
•Systolic Blood Pressure \>140 at current visit AND documented history of hypertension OR Systolic Blood Pressure \> 140 at current visit and at another visit in last 18 months OR Systolic Blood Pressure \>160 at current visit
•Sufficiently fluent in English to participate in study procedures
•Adequate vision and hearing to complete study procedures

Exclusion Criteria

•Clinically significant illness that may affect safety or completion per their treating Primary Care Physician or study physician
•End stage renal disease on dialysis
•Chronic active disease with expected life expectancy \< 2 years as determined by the study team

Related studies

Exercise Adherence and Cognitive Decline: Phase 2

NCT07127965 · Cognitive Decline

RECRUITINGPhase 3

A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

NCT07481981 · Pulmonary Arterial Hypertension

Mitigation of Health Effects in Older Adults With Hypertension by Reducing Exposure to Heat and Air Pollution

NCT07606859 · Hypertension Arterial, 65 Years Older

RECRUITINGPhase 4

Treatment With Aspirin After Preeclampsia: TAP Trial

NCT06281665 · Hypertensive Disorder of Pregnancy, Pre-Eclampsia, and more

Regional Innovation in Chronic Disease and Elderly Care

NCT07578090 · Hypertension, Cardiovascular Disease, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 9, 2021Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment33

Start dateOct 2020

Last updatedJul 9, 2021

Condition

Hypertension Cognitive Decline

Locations shown

University of Kansas Medical Center

Kansas City, Kansas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 9, 2021Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions